Experimental hantavirus drug ships to Europe as US passengers offered home quarantine
Read original atcidrap.umn.edu
FranceConfidence 90%Today
Emergency shipments of an experimental hantavirus drug are being sent to France, the Netherlands, and Spain for patients from the MV Hondius cruise ship, while US officials consider home quarantine for exposed American passengers in Nebraska.
Species mentioned
- humans
Source articles
Every claim above is derived from publicly available reporting. Click through to read the original at the publisher.
- PrimaryExperimental hantavirus drug ships to Europe as US passengers offered home quarantine
cidrap.umn.edu · 2026-06-01
CIDRAP reported on May 29, 2026, that emergency shipments of the experimental antiviral drug favipiravir are being sent to France, the Netherlands, and Spain to treat hantavirus patients from the MV Hondius cruise ship. Fujifilm Pharmaceuticals donated 1,400 tablets. US officials are considering allowing American passengers, exposed to the Andes hantavirus and quarantined in Nebraska, to return home under 24/7 surveillance for the remainder of their six-week quarantine.
- ReferenceHantavirus Patients Under Quarantine Could Go Home—If They Agree To 24/7 Surveillance, Report Says (Latest Updates) - Forbes
vertexaisearch.cloud.google.com · 2026-06-01
Americans quarantining in Nebraska after exposure to the Andes hantavirus on the M/V Hondius cruise ship were reportedly offered a deal to finish quarantine at home under 24/7 surveillance. A French national and two Spanish nationals tested positive after evacuation. The South African Department of Health confirmed the Andes virus strain. The WHO maintains the risk to the general population is low.
- ReferenceHantavirus outbreak 2026 - Public Health - European Commission
vertexaisearch.cloud.google.com · 2026-06-01
The European Commission was notified on May 2, 2026, of a cluster of severe respiratory illness aboard the MV Hondius, a Dutch-flagged wildlife expedition ship. Passengers and crew from 23 countries, including nine EU/EEA countries, were affected. The identified pathogen is Andes hantavirus, which is unique among hantaviruses for its potential for person-to-person transmission, typically requiring close and prolonged contact. The risk to the general population of the EU/EEA is assessed as very low. The Commission is actively involved in preparedness and response, including supporting the emer
Reminder
This report is an aggregated summary of public information for surveillance and awareness purposes only. It is not medical advice. For symptoms, exposure, or clinical decisions, contact a qualified clinician or your local public-health authority.